Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Vantage BioTrials’ President Nominated For Entrepreneur of the Year

July 13, 2015, Montréal, Canada – It is with pleasure to announce that Vantage BioTrials’ President, Vatché Bartekian, has been nominated by Ernst & Young for Entrepreneur of the Year 2015 in recognition of his vision, leadership and achievement in building a successful, growing and dynamic business.

“It is a great honor to be recognized by our peers, clients, colleagues and partners through this prestigious nomination.  Ernst & Young is a beacon of quality amongst the business management, accounting and finance industry, and similarly through the hard work of Vantage BioTrials’ employees we continue to establish ourselves as the go-to Canadian CRO for clinical trial management services.  This award is also shared by all of our employees who passionately perform their duties in order to protect the safety of the patients we care for in our clinical trials.  We pride ourselves each day for knowing that our work helps to bring to market safe and effective therapies for various conditions.” explains Vatché Bartekian.

 

About Vantage BioTrials Inc.

Vantage BioTrials Inc. is a leading Canadian Contract Research Organization (CRO) that provides Phase I-IV clinical trial management services to international biopharmaceutical, biotechnology, generic pharma and medical device companies within North America and Europe.

We are experts in implementing Risk-Based Management through the use of Quality by Design (QbD) methodologies, which helps accelerate the conduct of a study and reduces overall risk.  As a result this ensures that your trial is performed correctly, the first time!

For more information about Vantage BioTrials’ services and capabilities, please visit vantagebiotrials.com.

 

For more information

Vantage BioTrials, Inc.
Viken Bartekian
Co-Founder & Vice President of Business Development
viken.bartekian@vantagebiotrials.com

EN